文献速递细菌感染、耐药与抗菌药物

抗生素在感染靶位肝囊肿中的渗透:一项随机药代动力学试验

Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

这项前瞻性随机单剂药代动力学研究纳入20例患者、引流21个非感染性肝囊肿,评估四种抗生素在囊肿液中的渗透。囊肿液与血浆浓度比值中位数:甲氧苄啶12.2%、环丙沙星4.2%、多西环素1.6%、磺胺甲噁唑0.4%、哌拉西林0.3%、他唑巴坦0.2%。甲氧苄啶和环丙沙星渗透率最高,单次静脉给药后各药肝囊肿渗透差异大。

要点

  • 甲氧苄啶囊肿液/血浆浓度比值中位数12.2%,为受试药物中最高。
  • 环丙沙星比值中位数4.2%,多西环素1.6%,磺胺甲噁唑0.4%。
  • 哌拉西林0.3%、他唑巴坦0.2%,渗透率最低。

核心结论

  • 甲氧苄啶和环丙沙星在受试抗生素中渗透率最高。
  • 单次静脉给药后,各药肝囊肿渗透差异大。

研究设计与样本

  • 前瞻性、随机、单剂药代动力学研究。
  • 纳入20例患者,引流21个非感染性肝囊肿(组1:n=11,组2:n=10)。
  • 引流前静脉给予环丙沙星+哌拉西林/他唑巴坦(组1)或复方磺胺甲噁唑(甲氧苄啶/磺胺甲噁唑)+多西环素(组2)。
  • 引流期间收集囊肿液,引流前、中、后12小时内采血,用经验证的LC-MS/MS测药物浓度。

主要发现

  • 引流囊肿体积中位数700 mL,输注至引流时间中位数139分钟(IQR 120-188分钟)。
  • 囊肿液/血浆浓度比值中位数:环丙沙星4.2%(IQR 1.6%-8.9%),哌拉西林0.3%(IQR 0.0%-1.3%),他唑巴坦0.2%(IQR 0.0%-1.3%)。
  • 囊肿液/血浆浓度比值中位数:甲氧苄啶12.2%(IQR 6.3%-16.1%),磺胺甲噁唑0.4%(IQR 0.2%-3.8%),多西环素1.6%(IQR 0.9%-2.3%)。
  • 甲氧苄啶输注至囊肿引流时间与囊肿液/血浆浓度比值升高相关(P < 0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The EASL cystic liver disease guideline states that drug penetration at the site of infection (liver cyst) is essential for successful treatment, but pharmacokinetic (PK) data on cyst penetration are limited. OBJECTIVES: This study aims to investigate tissue penetration of four antibiotics in non-infected liver cysts and explores influencing factors. METHODS: We performed a prospective, randomized single-dose PK-study. Before percutaneous drainage of a non-infected liver cyst, an intravenous (IV) dose of either ciprofloxacin and piperacillin/tazobactam (group 1); or co-trimoxazole (trimethoprim/sulfamethoxazole) and doxycycline (group 2) was given. Cyst fluid was collected during drainage. Blood samples were obtained before, during and after drainage (within 12 h). Drug concentrations were measured with a validated LC-MS/MS. Primary outcome was liver cyst penetration, defined as the cyst-fluid-to-plasma concentration ratio (%) expressed as median (IQR). RESULTS: We included 20 patients, and 21 liver cysts were drained (group 1: n = 11, group 2: n = 10). Median drained cyst volume was 700 mL. Median time between infusion and drainage was 139 min (IQR 120-188 min). Median cyst-fluid-to-plasma concentration ratio was 4.2% (IQR 1.6%-8.9%) for ciprofloxacin, 0.3% (IQR 0.0%-1.3%) for piperacillin, 0.2% (IQR 0.0%-1.3%) for tazobactam, 12.2% (IQR 6.3%-16.1%) for trimethoprim, 0.4% (IQR 0.2%-3.8%) for sulfamethoxazole and 1.6% (IQR 0.9%-2.3%) for doxycycline. Time between trimethoprim infusion and cyst drainage was correlated with increased cyst-fluid-to-plasma concentration ratio (P < 0.01). CONCLUSIONS: Trimethoprim and ciprofloxacin have the highest penetration ratios amongst antibiotics tested. We found that liver cyst penetration varies widely between drugs after a single IV dose. CLINICAL TRIAL NUMBER: NTR8499The trial was originally registered in the Netherlands Trial Register (ID: NL7290), which was converted to the International Clinical Trials Registry Platform in 2022.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Bernts LHP, Brüggemann RJM, Jansen AME, et al. Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial. J Antimicrob Chemother. 2025. PMID: 39508371. doi:10.1093/jac/dkae394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。